Role of glutamine 17 of the bovine papillomavirus E5 protein in platelet-derived growth factor receptor activation and cell transformation

Journal of Virology

Volumn 72, Issue 11, 1998, Pages 8921-8932

  Klein, Ophir ^a   Polack, Glenda W ^a   Surti, Toral ^b   Kegler Ebo, Deena ^a,c   Smith, Steven O ^b,d   Dimaio, Daniel ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c CLARK ATLANTA UNIVERSITY   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; CATTLE; CELL TRANSFORMATION; DIMERIZATION; HYDROGEN BOND; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; VIRUS MUTATION;

EID: 0031691070     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.11.8921-8932.1998     Document Type: Article

References (31)

1. Bargmann, C. I., and R. A. Weinberg. 1988. Increased tyrosine kinase activity associated with the protein encoded by the actuated neu oncogene. Proc. Natl. Acad. Sci. USA 85:5394-5398.
2. Brooks, B. R., R. E. Bruccoleri, B. D. Olafson, D. J. State, S. Swaminathan, and M. Karplus. 1983. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J. Comp. Chem. 4:187-217.
3. Brünger, A. T. 1992. X-PLOR, version 3.1. Yale University, New Haven, Conn.
4. Burkhardt, A., M. Willingham, C. Gay, K.-T. Jeang, and R. Schlegel. 1989. The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology 170:334-339.
5. Cohen, B. D., D. J. Goldstein, L. Rutledge, W. C. Vass, D. R. Lowy, R. Schlegel, and J. Schiller. 1993. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. J. Virol. 67:5303-5311.
6. Drummond-Barbosa, D., R. R. Vaillancourt, A. Kazlauskas, and D. DiMaio. 1995. Ligand-independent activation of the platelet-derived growth factor β receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling. Mol. Cell. Biol. 5:2570-2581.
7. Drummond-Barbosa, D., and D. DiMaio. 1997. Virocrine transformation. Biochim. Biophys. Acta 1332:M1-M17.
8. Engh, R. A., and R. Huber. 1991. Accurate bond and angle parameters for X-ray protein-structure refinement. Acta Cryst. A47:392-400.
9. Goldstein, D. J., T. Andresson, J. J. Sparkowski, and R. Schlegel. 1992. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. EMBO J. 11:4851-4859.
10. Goldstein, D. J., W. Li, L.-M. Wang, M. A. Heidaran, S. A. Aaronson, R. Shinn, R., Schlegel, and J. H. Pierce. 1994. The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the β-type receptor for platelet-derived growth factor but not other tyrosine kinase-containing receptors to induce cellular transformation. J. Virol. 68:4432-4441.
11. Gregoret, L. M., S. D. Rader, R. J. Fletterick, and F. E. Cohen. 1991. Hydrogen bonds involving sulfur atoms in proteins. Proteins Struct. Funct. Genet. 9:99-107.
12. Honig, B. H., and W. L. Hubbell. 1984. Stability of "salt bridges" in membrane proteins. Proc. Natl. Acad. Sci. USA 81:5412-5416.
13. Horwitz, B. H., A. L. Burkhardt, R. Schlegel, and D. DiMaio. 1988. 44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids. Mol. Cell. Biol. 8:4071-4078.
14. Kegler-Ebo, D. M., C. M. Docktor, and D. DiMaio. 1994. Codon cassette mutagenesis: a general method to insert or replace individual codons by using universal mutagenic cassettes. Nucleic Acids Res. 22:1593-1599.
15. +. J. Am. Chem. Soc. 97:955-965.
16. Kovalenko, M., A. Gazit, A. Böhmer, C. Rorsman, L. Rönnstrand, C.-H. Heldin, J. Waltenberger, F.-D. Böhmer, and A. Levitzki. 1994. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res. 54:6106-6114.
17. Lai, C. C., C. Henningson, and D. DiMaio. Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor receptor. Submitted for publication.
18. Landolt-Marticorena, C., K. A. Williams, C. M. Deber, and R. A. F. Reithmeier. 1993. Non-random distribution of amino acids in the transmembrane segments of human type I single span membrane proteins. J. Mol. Biol. 229:602-608.
19. Lemmon, M. A., J. M. Flanagan, H. R. Treutlein, J. Zhang, and D. M. Engelman. 1992. Sequence specificity in the dimerization of transmembrane α-helices. Biochemistry 31:12719-12725.
20. Meyer, A. N., Y.-F. Xu, M. K. Webster, A. S. Smith, and D. J. Donoghue. 1994. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein. Proc. Natl. Acad. Sci. USA 91:4634-4638.
21. Nilson, L., and D. DiMaio. 1993. Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein. Mol. Cell. Biol. 13:4137-4145.
22. Nilson, L. A., R. Gottlieb, G. W. Polack, and D. DiMaio. 1995. Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous β receptor for platelet-derived growth factor in mouse C127 cells. J. Virol. 69:5869-5874.
23. Petti, L., L. A. Nilson, and D. DiMaio. 1991. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein. EMBO J. 10:845-855.
24. Petti, L., and D. DiMaio. 1992. Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells. Proc. Natl. Acad. Sci. USA 89:6736-6740.
25. Petti, L., and D. DiMaio. 1994. Specific interaction between the bovine papillomavirus E5 transforming protein and the β receptor for platelet-derived growth factor in stably transformed and acutely transfected cells. J. Virol. 68:3582-3592.
26. Petti, L. M., V. Reddy, S. O. Smith, and D. DiMaio. 1997. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein. J. Virol. 71:7318-7327.
27. Sparkowski, J., J. Anders, and R. Schlegel. 1994. Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants. J. Virol. 68:6120-6123.
28. Sparkowski, J., M. Mense, J. Anders, and R. Schlegel. 1996. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation. J. Virol. 70:2420-2430.
29. Staebler, A., J. H. Pierce, S. Brazinski, M. A. Heidaran, W. Li, R. Schlegel, and D. J. Goldstein. 1995. Mutational analysis of the β-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein. J. Virol. 69:6507-6517.
30. Surti, T., O. Klein, K. Ascheim, D. DiMaio, and S. O. Smith. 1998. Structural models of the bovine papillomavirus E5 protein. Proteins Struct. Funct. Genet., in press.
31. Williams, K. A., and C. M. Deber. 1991. Proline residues in transmembrane helices: structural or dynamic role? Biochemistry 30:8919-8923.